$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

$bdrl Overview Financials Valuation SEC Filings Company Website

2014 Q4 Form 10-Q Financial Statement

#000114420414068129 Filed on November 14, 2014

Income Statement

Concept	2014 Q4	2014 Q3	2013 Q3
Revenue	$6.060M	$8.659M	$6.823M
YoY Change	-15.6%	26.91%	-20.75%
Cost Of Revenue	$3.820M	$5.173M	$4.550M
YoY Change	-24.8%	13.69%	-14.15%
Gross Profit	$2.240M	$3.486M	$2.273M
YoY Change	6.67%	53.37%	-31.33%
Gross Profit Margin	36.96%	40.26%	33.31%
Selling, General & Admin	$2.040M	$1.968M	$2.117M
YoY Change	-3.77%	-7.04%	-8.75%
% of Gross Profit	91.07%	56.45%	93.14%
Research & Development	$780.0K	$865.0K	$780.0K
YoY Change	-13.33%	10.9%	-4.88%
% of Gross Profit	34.82%	24.81%	34.32%
Depreciation & Amortization	$340.0K	$360.0K	$310.0K
YoY Change	0.0%	16.13%	-11.43%
% of Gross Profit	15.18%	10.33%	13.64%
Operating Expenses	$2.830M	$2.833M	$2.897M
YoY Change	-6.6%	-2.21%	-7.44%
Operating Profit	-$590.0K	$653.0K	-$624.0K
YoY Change	-36.56%	-204.65%	-446.67%
Interest Expense	-$60.00K	$69.00K	$64.00K
YoY Change	-14.29%	7.81%	-171.11%
% of Operating Profit		10.57%
Other Income/Expense, Net			-$64.00K
YoY Change
Pretax Income	-$640.0K	$584.0K	-$688.0K
YoY Change	-35.35%	-184.88%	-864.44%
Income Tax	$30.00K	$0.00	$0.00
% Of Pretax Income		0.0%
Net Earnings	-$670.0K	$584.0K	-$688.0K
YoY Change	-32.32%	-184.88%	-864.44%
Net Earnings / Revenue	-11.06%	6.74%	-10.08%
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.11	$0.09	-$0.11
COMMON SHARES
Basic Shares Outstanding	6.229M shares	6.226M shares	6.216M shares
Diluted Shares Outstanding		6.320M shares	6.216M shares

Balance Sheet

Concept	2014 Q4	2014 Q3	2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$230.0K	$1.430M	$50.00K
YoY Change	228.57%	2760.0%	-70.59%
Cash & Equivalents	$232.0K	$1.430M	$54.00K
Short-Term Investments
Other Short-Term Assets	$650.0K	$1.120M	$910.0K
YoY Change	-25.29%	23.08%	-32.09%
Inventory	$9.257M	$8.014M	$9.320M
Prepaid Expenses
Receivables	$2.425M	$2.681M	$2.870M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.57M	$13.24M	$13.16M
YoY Change	-4.49%	0.62%	-22.72%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.923M	$3.879M	$3.766M
YoY Change	5.74%	3.0%	-7.24%
Goodwill	$493.0K	$493.0K	$493.0K
YoY Change	0.0%	0.0%
Intangibles	$645.0K	$617.0K	$483.0K
YoY Change	-18.56%	27.74%
Long-Term Investments
YoY Change
Other Assets	$28.00K	$135.0K	$168.0K
YoY Change	-82.39%	-19.64%	-97.32%
Total Long-Term Assets	$8.679M	$9.160M	$9.748M
YoY Change	-8.5%	-6.03%	-29.82%
TOTAL ASSETS
Total Short-Term Assets	$12.57M	$13.24M	$13.16M
Total Long-Term Assets	$8.679M	$9.160M	$9.748M
Total Assets	$21.24M	$22.40M	$22.91M
YoY Change	-6.17%	-2.21%	-25.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.351M	$1.491M	$942.0K
YoY Change	-9.51%	58.28%	-49.35%
Accrued Expenses	$870.0K	$870.0K	$1.500M
YoY Change	45.0%	-42.0%	-7.41%
Deferred Revenue
YoY Change
Short-Term Debt	$1.270M	$1.000M	$1.190M
YoY Change	-0.78%	-15.97%	-66.0%
Long-Term Debt Due	$286.0K	$3.900M	$274.0K
YoY Change	5.93%	1323.36%	1.48%
Total Short-Term Liabilities	$3.804M	$7.280M	$3.920M
YoY Change	4.02%	85.71%	-46.3%
LONG-TERM LIABILITIES
Long-Term Debt	$3.607M	$60.00K	$3.959M
YoY Change	-7.35%	-98.48%	-5.96%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$3.607M	$60.00K	$3.959M
YoY Change	-7.35%	-98.48%	-5.96%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.804M	$7.280M	$3.920M
Total Long-Term Liabilities	$3.607M	$60.00K	$3.959M
Total Liabilities	$7.411M	$7.410M	$7.879M
YoY Change	-1.84%	-5.95%	-31.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.096M		-$2.202M
YoY Change	28.24%
Common Stock	$26.44M		$26.13M
YoY Change	0.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$7.255M		$7.308M
YoY Change	-0.73%
Treasury Stock Shares	2.202M shares	2.235K shares	2.248M shares
Shareholders Equity	$13.74M	$15.00M	$15.00M
YoY Change
Total Liabilities & Shareholders Equity	$21.24M	$22.40M	$22.91M
YoY Change	-6.17%	-2.22%	-25.91%

Cashflow Statement

Concept	2014 Q4	2014 Q3	2013 Q3
OPERATING ACTIVITIES
Net Income	-$670.0K	$584.0K	-$688.0K
YoY Change	-32.32%	-184.88%	-864.44%
Depreciation, Depletion And Amortization	$340.0K	$360.0K	$310.0K
YoY Change	0.0%	16.13%	-11.43%
Cash From Operating Activities	-$1.090M	$2.330M	$420.0K
YoY Change	-309.62%	454.76%	-16.0%
INVESTING ACTIVITIES
Capital Expenditures	$350.0K	$90.00K	$60.00K
YoY Change	-33.96%	50.0%	-75.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change			-100.0%
Cash From Investing Activities	-$350.0K	-$90.00K	-$60.00K
YoY Change	-33.96%	50.0%	-45.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	250.0K	-860.0K	-480.0K
YoY Change	1150.0%	79.17%	11.63%
NET CHANGE
Cash From Operating Activities	-1.090M	2.330M	420.0K
Cash From Investing Activities	-350.0K	-90.00K	-60.00K
Cash From Financing Activities	250.0K	-860.0K	-480.0K
Net Change In Cash	-1.190M	1.380M	-120.0K
YoY Change	-12000.0%	-1250.0%	200.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.090M	$2.330M	$420.0K
Capital Expenditures	$350.0K	$90.00K	$60.00K
Free Cash Flow	-$1.440M	$2.240M	$360.0K
YoY Change	14300.0%	522.22%	38.46%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2014Q3	us-gaap	Line Of Credit LineOfCredit	1000000	USD
CY2014Q3	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	1826000	USD
	us-gaap	Line Of Credit Facility Expiration Date1 LineOfCreditFacilityExpirationDate1	2015-02-01
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1022000	shares
	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1443000	shares
CY2013Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1840000	shares
CY2014Q3	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1015000	shares
CY2014Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	4942000	USD
CY2013Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	5351000	USD
CY2014Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2718000	USD
CY2013Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	2815000	USD
CY2014Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4835000	USD
CY2013Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5394000	USD
CY2014Q3	us-gaap	Inventory Gross InventoryGross	12495000	USD
CY2013Q4	us-gaap	Inventory Gross InventoryGross	13560000	USD
CY2014Q3	us-gaap	Inventory Net InventoryNet	8014000	USD
CY2013Q4	us-gaap	Inventory Net InventoryNet	8975000	USD
CY2014Q3	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4481000	USD
CY2013Q4	bdr	Inventory Value Before Reserves InventoryValueBeforeReserves	4585000	USD
CY2014Q3	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2470000	USD
CY2013Q4	us-gaap	Inventory Lifo Reserve InventoryLIFOReserve	2470000	USD
CY2014Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	2011000	USD
CY2013Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	2115000	USD
CY2013	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.6	pure
	bdr	Percentage Of Fifo Inventory Non Current For Finished Goods PercentageOfFifoInventoryNonCurrentForFinishedGoods	0.58	pure
	us-gaap	Inventory Related Text InventoryRelatedText	Inventories are stated at the lower of cost, determined by the first-in, first-out (FIFO) method, or market
CY2013Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	24000	USD
CY2013Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	149000	USD
CY2013Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3657000	USD
CY2013Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3893000	USD
CY2013Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	63000	USD
CY2013Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2013Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2014Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1430000	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67000	USD
CY2014Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2681000	USD
CY2013Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	3241000	USD
CY2014Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	702000	USD
CY2013Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	458000	USD
CY2014Q3	us-gaap	Prepaid Pension Costs PrepaidPensionCosts	415000	USD
CY2013Q4	us-gaap	Prepaid Pension Costs PrepaidPensionCosts	415000	USD
CY2014Q3	us-gaap	Assets Current AssetsCurrent	13242000	USD
CY2013Q4	us-gaap	Assets Current AssetsCurrent	13156000	USD
CY2014Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3879000	USD
CY2013Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3710000	USD
CY2014Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	617000	USD
CY2013Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	792000	USD
CY2014Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2025000	USD
CY2013Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2216000	USD
CY2014Q3	us-gaap	Goodwill Goodwill	493000	USD
CY2013Q4	us-gaap	Goodwill Goodwill	493000	USD
CY2014Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	135000	USD
CY2013Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	159000	USD
CY2014Q3	us-gaap	Assets Assets	22402000	USD
CY2013Q4	us-gaap	Assets Assets	22641000	USD
CY2013Q4	us-gaap	Line Of Credit LineOfCredit	1275000	USD
CY2014Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	3900000	USD
CY2013Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	270000	USD
CY2014Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1491000	USD
CY2013Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1493000	USD
CY2014Q3	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	723000	USD
CY2013Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	446000	USD
CY2013Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	26190000	USD
CY2013Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3194000	USD
CY2013Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-668000	USD
CY2013Q4	us-gaap	Treasury Stock Value TreasuryStockValue	7308000	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	15028000	USD
CY2013Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22641000	USD
CY2008	us-gaap	Line Of Credit Facility Increase Decrease Other Net LineOfCreditFacilityIncreaseDecreaseOtherNet	9350000	USD
CY2008Q3	us-gaap	Line Of Credit LineOfCredit	8000000	USD
CY2014Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	196000	USD
CY2013Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	196000	USD
CY2014Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2013Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000	shares
CY2014Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2013Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2014Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2013Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000	shares
CY2014Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465	shares
CY2013Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8465	shares
CY2014Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	2235	shares
CY2013Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2248	shares
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	20688000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	23065000	USD
CY2013Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	6823000	USD
CY2014Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	8659000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	13475000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	14347000	USD
CY2013Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	4550000	USD
CY2014Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	5173000	USD
	us-gaap	Gross Profit GrossProfit	7213000	USD
	us-gaap	Gross Profit GrossProfit	8718000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	2273000	USD
CY2014Q3	us-gaap	Gross Profit GrossProfit	3486000	USD
	us-gaap	Selling Expense SellingExpense	2585000	USD
	us-gaap	Selling Expense SellingExpense	2500000	USD
CY2013Q3	us-gaap	Selling Expense SellingExpense	874000	USD
CY2014Q3	us-gaap	Selling Expense SellingExpense	807000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3777000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3631000	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1243000	USD
CY2014Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1161000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2471000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2634000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	780000	USD
CY2014Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	865000	USD
	us-gaap	Operating Expenses OperatingExpenses	8833000	USD
	us-gaap	Operating Expenses OperatingExpenses	8765000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	2897000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	2833000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1620000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-47000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-624000	USD
CY2014Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	653000	USD
	us-gaap	Interest Expense InterestExpense	210000	USD
	us-gaap	Interest Expense InterestExpense	183000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	64000	USD
CY2014Q3	us-gaap	Interest Expense InterestExpense	69000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1830000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-230000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-688000	USD
CY2014Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	584000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	-1830000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-230000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-688000	USD
CY2014Q3	us-gaap	Net Income Loss NetIncomeLoss	584000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.29
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2014Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.09
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6216000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6220000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6216000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6226000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6216000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6220000	shares
CY2013Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6216000	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6320000	shares
	us-gaap	Share Based Compensation ShareBasedCompensation	204000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	186000	USD
	us-gaap	Depreciation Depreciation	344000	USD
	us-gaap	Depreciation Depreciation	339000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	632000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	735000	USD
	us-gaap	Inventory Write Down InventoryWriteDown	0	USD
	us-gaap	Inventory Write Down InventoryWriteDown	107000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-590000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-560000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2038000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-958000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	191000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	244000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-57000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-24000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-503000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	272000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	1341000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	2707000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	508000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	373000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	369000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-474000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-877000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-1059000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-275000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	207000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	204000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-1266000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	-467000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-399000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	1363000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	453000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54000	USD
	us-gaap	Interest Paid InterestPaid	201000	USD
	us-gaap	Interest Paid InterestPaid	190000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2014-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2014
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Registrant Name EntityRegistrantName	BLONDER TONGUE LABORATORIES INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001000683
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
	dei	Trading Symbol TradingSymbol	BDR
CY2014Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6229070	shares
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12000	USD

Files In Submission

Name	View Source	Status
0001144204-14-068129-index-headers.html	Edgar Link	pending
0001144204-14-068129-index.html	Edgar Link	pending
0001144204-14-068129.txt	Edgar Link	pending
0001144204-14-068129-xbrl.zip	Edgar Link	pending
bdr-20140930.xml	Edgar Link	completed
bdr-20140930.xsd	Edgar Link	pending
bdr-20140930_cal.xml	Edgar Link	unprocessable
bdr-20140930_def.xml	Edgar Link	unprocessable
bdr-20140930_lab.xml	Edgar Link	unprocessable
bdr-20140930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v392971_10q.htm	Edgar Link	pending
v392971_ex31-1.htm	Edgar Link	pending
v392971_ex31-2.htm	Edgar Link	pending
v392971_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl

2014 Q4 Form 10-Q Financial Statement

#000114420414068129 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL BLONDER TONGUE LABORATORIES INC Stock $bdrl

2014 Q4 Form 10-Q Financial Statement

#000114420414068129 Filed on November 14, 2014

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BDRL
BLONDER TONGUE LABORATORIES INC Stock $bdrl